The cluster is dominated by passive rebalancing; active manager interest is absent. Monitor for 13F filings from active funds or insiders to gauge genuine conviction. The 45-day reporting lag means these positions are already stale.
MGNX drugs
MGNX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $4.01entry
- T+1 · 5mo ago −1.25%α −1.79% · $3.96
- T+5 · 5mo ago −1.25%α −1.68% · $3.96
- T+20 · 4mo ago +13.97%α +12.07% · $4.57
- T+60 · 2mo ago +9.73%α +5.33% · $4.40
How similar events traded
Executive Summary
Four institutions increased their MGNX positions in Q3 2025 while one reduced, resulting in net buying of approximately $2M. However, the buying is dominated by passive managers (Morgan Stanley, Wells Fargo, Invesco) and quant fund RenTech, suggesting index rebalancing or quantitative signals rather than fundamental conviction. The sole seller, Schwab, nearly exited its position. Given the small absolute dollar amounts and passive nature, the signal is weak.
Key Financial Metrics
Institutional Positions
Net institutional flow: $2.0M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +121.7% | $1.7M | $1.1M |
| RenTech | ADD | +28.2% | $2.9M | $1.3M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Schwab | NEAR_EXIT | -91% | $405.0K | -$354.1K |
Key Facts
- Morgan Stanley doubled its MGNX holdings (446K → 989K shares, value $540K → $1.7M).
- RenTech added 28.2% (1.33M → 1.70M shares, value $1.6M → $2.9M).
- Schwab reduced its stake by 91% (334K → 30K shares, value $405K → $50K).
- Net institutional buying of ~$2.0M, but mostly from passive index funds.
- MGNX market cap is $246M; the cluster represents a tiny fraction of outstanding shares.
Financial Impact
4 buyers accumulated $2.4M in new positions while 1 seller reduced holdings by $354K, net +$2.0M.
Risk Factors
- Passive buying may be reversed in subsequent quarters with no fundamental catalyst.
- Small dollar amounts relative to market cap limit price impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MGNX-2025-Q3 |
Track record
21 reports on MGNX
4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +130.41% at T+60 after the Feb 28, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $2.22 settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $2.31 settles Feb 12
- Nov 12, 20264d ago Press Release Bearish 5/10 Entry $2.20 settles Feb 11
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 settles Feb 2
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $2.31 settles Feb 2
- Oct 26, 202621d ago Press Release Bullish 6/10 Entry $2.19 settles Jan 22
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $2.19 settles Jan 22
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $2.25 settles Jan 21
- Oct 15, 20264w ago Press Release Neutral 3/10 Entry $3.25 settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers